## CL: Colgate-Palmolive Company - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -0.8% below STRENGTH zone (4.0-10.0%); PEG 2.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($75.49)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Is Colgate-Palmolive’s Dividend Hike Amid AI Spend and Downgrade Altering The Investment Case For Colgate-Palmolive (CL)?**
- Source: Simply Wall Street | 20251218T004515 | Neutral | Relevance: 100%
- Colgate-Palmolive recently declared a dividend hike while facing an Argus downgrade due to profitability concerns amidst rising raw material and tariff costs. The company is investing in AI and automation to drive efficiency and support its 2030 Strategy to counter these headwinds. Investors need to weigh these efforts against the risks to margins and consider various fair value estimates for the stock.

**2. Montecito Bank & Trust Buys Shares of 14,974 Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251219T111507 | Neutral | Relevance: 100%
- Montecito Bank & Trust initiated a new position in Colgate-Palmolive Company, purchasing 14,974 shares valued at approximately $1.197 million in Q3. The company reported Q3 EPS of $0.91, beating estimates, despite revenue slightly missing forecasts, with the stock recently trading around $77.73. Colgate-Palmolive declared a quarterly dividend of $0.52 (2.7% yield), while analysts have a consensus target price of $88.81 with mixed ratings.

**3. Inside Colgate’s Enterprise-Wide AI Pus**
- Source: PYMNTS.com | 20251219T010809 | Bullish | Relevance: 100%
- Colgate-Palmolive is expanding its use of artificial intelligence beyond traditional chatbots, integrating agentic systems and internal platforms to drive product innovation and R&D. The company's AI Hub allows employees to develop tailored AI assistants, while generative AI is being used to accelerate biomaterials development and sensory design. This enterprise-wide approach emphasizes innovation and efficiency, with AI agents supporting decision-making in operations and supply chain management.

**4. August 2026 Options Now Available For Colgate-Palmolive (CL)**
- Source: Nasdaq | 20251218T170751 | Somewhat-Bullish | Relevance: 100%
- New August 2026 options are now available for Colgate-Palmolive (CL), offering potential opportunities for options traders. The article highlights a put contract at a $75.00 strike price and a call contract at an $80.00 strike price, detailing potential returns and risks for investors. These new contracts provide a longer expiration horizon, influencing premium values.

**5. Texas Permanent School Fund Corp Reduces Holdings in Colgate-Palmolive Company $CL**
- Source: MarketBeat | 20251218T104908 | Neutral | Relevance: 100%
- Texas Permanent School Fund Corp significantly reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 50.2% in Q2, selling 57,291 shares, leaving it with 56,895 shares valued at $5.17 million. Despite the institutional selling, Colgate-Palmolive reported strong Q3 earnings, beating EPS estimates and announcing a $0.52 quarterly dividend. Analysts maintain a "Moderate Buy" rating with an average target of $88.75, even after some price target adjustments.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-18 | JP Morgan | $88 | $87 | +1% |
| 2025-12-11 | Argus Research | $0 | $0 | 0% |
| 2025-12-09 | RBC Capital | $88 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-18 | JP Morgan | main | Overweight |
| 2025-12-11 | Argus Research | down | Hold |
| 2025-12-09 | RBC Capital | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.07M) |
| Sells | 7 ($0.28M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 37.8% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.3% (+0.2%)
- Blackrock Inc.: 8.6% (+0.5%)
- State Street Corpora: 6.0% (+0.2%)
- Price (T.Rowe) Assoc: 4.0% (-11.5%)
- Geode Capital Manage: 2.7% (+4.1%)

### Key Risks

1. Long-term trend broken: trading 8.6% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.96 signals overvaluation risk, limited margin of safety. Forward P/E 20.4x stretched relative to 5% growth. Quality metrics strong (ROE 294%, ROA 15%). Balance sheet: $1.1B free cash flow. Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $63.3B |
| Beta | 0.29 |
| 52W Range | $74.55 - $100.18 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.96 |
| Forward P/E | 20.4 |
| Current P/E | 21.4 |
| YoY Growth | 5.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.1% to -0.8% (-1.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.8pp (needs >4.0% for momentum thesis). Below SMA200 (0.91x), long-term trend not supportive. RSI neutral at 49. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: +SUH (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.76% (CS: 42) | Neutral |
| RSI_14 | 49.4 | Neutral |
| MACD Histogram | 0.03 | Bullish |
| vs SMA20 | 0.996x | Below |
| vs SMA50 | 1.001x | Above |
| vs SMA200 | 0.914x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $78.35
- **Stop Loss:** $75.49 (3.7% risk)
- **Target:** $81.21 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 419
- **Position Value:** $32,828.65
- **Portfolio %:** 32.83%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-01-30 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.89 | $0.91 | +2.4% |
| 2025Q2 | $0.89 | $0.92 | +2.8% |
| 2025Q1 | $0.86 | $0.91 | +6.1% |
| 2024Q4 | $0.89 | $0.91 | +2.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*